Evidence map›Paper›PMID 39044922›Full record

ArticleJournal of medicine and life2024

QEEG indices in traumatic brain injury - insights from the CAPTAIN RTMS trial.

Verişezan Roşu Olivia, Diana Chira, Vlad-Florin Chelaru, Chertic Dăbală Diana, Livinț Popa Livia, Ana-Maria Buruiană, Fior Dafin Mureşanu

Abstract read
In one paragraph

Article in Journal of medicine and life, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Verişezan Roşu OliviaDepartment of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Diana ChiraRoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania.
Vlad-Florin ChelaruRoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania.
Chertic Dăbală DianaDepartment of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Livinț Popa LiviaDepartment of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Ana-Maria BuruianăRoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania.
Fior Dafin MureşanuDepartment of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This secondary analysis of the CAPTAIN-RTMS trial data focused on the significance of quantitative electroencephalography (qEEG) indices as indicators of recovery in patients with traumatic brain injury (TBI). By focusing on the delta alpha ratio (DAR), delta theta/alpha beta ratio (DTABR), and theta beta ratio (TBR), this study explored the shifts in brainwave activity as a response to an integrative treatment regimen of repetitive transcranial magnetic stimulation (rTMS) combined with the neurotrophic agent Cerebrolysin. Findings revealed significant increases in DAR and DTABR, suggesting changes in neurophysiological dynamics after treatment. However, variations in TBR were inconclusive in providing clear electrophysiological insights. These results indicate that further research is necessary to describe and understand the underlying mechanisms of brain recovery and to develop refined treatment frameworks for patients with TBI.

Indexed as

Brain Injuries, TraumaticElectroencephalographyTranscranial Magnetic StimulationAdultAmino AcidsFemaleHumansMaleMiddle AgedAmino AcidscerebrolysinCerebrolysinDARDTABRqEEGrTMSTBITBR

Identifiers

PMID39044922
PMCPMC11262599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.